Human mast cells stimulate activated T cells: Implications for multiple sclerosis

Annals of the New York Academy of Sciences

Volumn 1144, Issue , 2008, Pages 74-82

  Theoharides, Theoharis C ^a   Kempuraj, Duraisamy ^a   Kourelis, Taxiarchis ^a   Manola, Akrivi ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Luteolin; Mast cells; Multiple sclerosis; T cells

Indexed keywords

BRADYKININ; CARBOXYPEPTIDASE A; CHYMASE; CORTICOTROPIN RELEASING FACTOR; ENDORPHIN; ENDOTHELIN; FLAVONE; FLAVONOID; HEPARIN; HISTAMINE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LUTEOLIN; METALLOPROTEINASE; MYELIN BASIC PROTEIN; NEUROTENSIN; PHOSPHOLIPASE; PROSTAGLANDIN D2; SEROTONIN; SOMATOSTATIN; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UROCORTIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGIC ENCEPHALOMYELITIS; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CELL INTERACTION; CELL STIMULATION; CONFERENCE PAPER; DEMYELINATING DISEASE; ENCEPHALITIS; MALE; MAST CELL; MULTIPLE SCLEROSIS; NONHUMAN; RAT; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 56649100738     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1418.029     Document Type: Conference Paper

References (77)

1. Smith, K.J. & W.I. McDonald. 1999. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1390 : 1649 1673.
2. Gregory, G.D., S.S. Raju, S. Winandy, et al. 2006. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J. Clin. Invest. 116 : 1327 1336.
3. Weaver, C.T., R.D. Hatton, P.R. Mangan, et al. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25 : 821 852.
4. Pedotti, R., J.J. DeVoss, S. Youssef, et al. 2003. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. USA 100 : 1867 1872.
5. Weaver, C.T., L.E. Harrington, P.R. Mangan, et al. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 : 677 688.
6. Kimura, A., T. Naka & T. Kishimoto. 2007. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc. Natl. Acad. Sci. USA 104 : 12099 12104.
7. Mekori, Y.A. & D.D. Metcalfe. 2000. Mast cells in innate immunity. Immunol. Rev. 173 : 131 140.
8. Kanbe, N., M. Kurosawa, H. Nagata, et al. 1999. Cord blood-derived human cultured mast cells produce transforming growth factor beta 1. Clin. Exp. Allergy 29 : 105 113.
9. Lassmann, H. & R.M. Ransohoff. 2004. The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal. Trends Immunol. 25 : 132 137.
10. Pedotti, R., J.J. De Voss, L. Steinman, et al. 2003. Involvement of both "allergic" and "autoimmune" mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24 : 479 484.
11. Esposito, P., N. Chandler, K. Kandere-Grzybowska, et al. 2002. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 303 : 1061 1066.
12. Ibrahim, M.Z., A.T. Reder, R. Lawand, et al. 1996. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70 : 131 138.
13. Esposito, P., D. Gheorghe, K. Kandere, et al. 2001. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888 : 117 127.
14. Stone, L.A., M.E. Smith, P.S. Albert, et al. 1995. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 45 : 1122 1126.
15. Minagar, A. & J.S. Alexander. 2003. Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9 : 540 549.
16. Theoharides, T.C. & A. Konstantinidou. 2007. Corticotropin-releasing hormone and the blood-brain-barrier. Front. Biosci. 12 : 1615 1628.
17. Cao, J., C.L. Curtis & T.C. Theoharides. 2006. Corticotropin- releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol. Pharmacol. 69 : 998 1006.
18. 2 can stimulate mast cell degranulation. Brain Res. 444 : 195 198.
19. Theoharides, T.C., V. Dimitriadou, R.J. Letourneau, et al. 1993. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain demyelination: changes resembling early stages of demyelination. Neuroscience 57 : 861 871.
20. Rozniecki, J.J., S.L. Hauser, M. Stein, et al. 1995. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37 : 63 66.
21. Molino, M., E.S. Barnathan, R. Numerof, et al. 1997. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272 : 4043 4049.
22. Lock, C., G. Hermans, R. Pedotti, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 : 500 508.
23. Bomprezzi, R., M. Ringner, S. Kim, et al. 2003. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 12 : 2191 2199.
24. Galli, S.J., S. Nakae & M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 : 135 142.
25. Galli, S.J. & S. Nakae. 2003. Mast cells to the defense. Nat. Immunol. 4 : 1160 1162.
26. Nakae, S., H. Suto, M. Kakurai, et al. 2005. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 102 : 6467 6472.
27. Theoharides, T.C. & D.E. Cochrane. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146 : 1 12.
28. Krüger, P.G. 2001. Mast cells and multiple sclerosis: a quantitative analysis. Neuropathol. Appl. Neurobiol. 27 : 275 280.
29. Galli, S.J., J. Kalesnikoff, M.A. Grimbaldeston, et al. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23 : 749 786.
30. Salamon, P., N.G. Shoham, R. Gavrieli, et al. 2005. Human mast cells release interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 60 : 1316 1319.
31. Ott, V.L., J.C. Cambier, J. Kappler, et al. 2003. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat. Immunol. 4 : 974 981.
32. Jutel, M., T. Watanabe, S. Klunker, et al. 2001. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413 : 420 425.
33. Bebo, B.F.J., T. Yong, E.L. Orr, et al. 1996. Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45 : 340 348.
34. Galli, S.J. 1990. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62 : 5 33.
35. Tartaglia, L.A., D.V. Goeddel, C. Reynolds, et al. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151 : 4637 4641.
36. Martino, G., R. Furlan & P.L. Poliani. 2000. [The pathogenic role of inflammation in multiple sclerosis]. Rev. Neurol. 30 : 1213 1217.
37. Malamud, V., A. Vaaknin, O. Abramsky, et al. 2003. Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis. J. Neuoimmunol. 138 : 115 122.
38. Dery, O., C.U. Corvera, M. Steinhoff, et al. 1998. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274 : C1429 C1452.
39. Macey, M.G., L. Hou, T. Milne, et al. 1998. A CD4+ proliferation of large granular lymphocytes expresses the protease activated receptor-1 Br. J. Haematol. 101 : 78 81.
40. Dietsch, G.N. & D.J. Hinrichs. 1991. Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell Immunol. 135 : 541 548.
41. Kempuraj, D., N.G. Papadopoulou, M. Lytinas, et al. 2004. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145 : 43 48.
42. Cao, J., N. Papadopoulou, D. Kempuraj, et al. 2005. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J. Immunol. 174 : 7665 7675.
43. + cord blood cells. Blood 94 : 496 508.
44. Bongioanni, P., S. Mosti, M.R. Romano, et al. 2000. Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis. Eur. J. Neurol. 7 : 291 297.
45. Hirano, T., K. Yasukawa, H. Harada, et al. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B cell lymphocytes to produce immunoglobulin. Nature 324 : 73 76.
46. Hu, Z.Q., W.H. Zhao & T. Shimamura. 2007. Regulation of mast cell development by inflammatory factors. Curr. Med. Chem. 14 : 3044 3050.
47. Oliveira, S.H. & N.W. Lukacs. 2003. Stem cell factor: a hematopoietic cytokine with important targets in asthma. Curr. Drug Targets Inflamm. Allergy 2 : 313 318.
48. Matsuzawa, S., K. Sakashita, T. Kinoshita, et al. 2003. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J. Immunol. 170 : 3461 3467.
49. Wiener, Z., A. Falus & S. Toth. 2004. IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced-IL-9- production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 26 : 122 130.
50. Bagga, S., K.S. Price, D.A. Lin, et al. 2004. Lysophosphatidic acid accelerates the development of human mast cells. Blood 104 : 4080 4087.
51. Toru, H., M. Eguchi, R. Matsumoto, et al. 1998. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91 : 187 195.
52. Karimi, K., F.A. Redegeld, R. Blom, et al. 2000. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp. Hematol. 28 : 626 634.
53. Theoharides, T.C. & D. Kalogeromitros. 2006. The critical role of mast cell in allergy and inflammation. Ann. N. Y. Acad. Sci. 1088 : 78 99.
54. Goetzl, E.J., T. Chernov, F. Renold, et al. 1985. Neuropeptide regulation of the expression of immediate hypersensitivity. J. Immunol. 135 : 802s 805s.
55. Kempuraj, D., M. Tagen, B.P. Iliopoulou, et al. 2008. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br. J. Pharmacol. Sept. 22 [Epub ahead of print].
56. Brill, A., D. Baram, U. Sela, et al. 2004. Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro. Clin. Exp. Allergy 34 : 1725 1731.
57. Redegeld, F.A. & F.P. Nijkamp. 2005. Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? Trends Immunol. 24 : 181 185.
58. Brown, M.A., M. Tanzola & M. Robbie-Ryan. 2002. Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. 38 : 1373 1378.
59. Gregory, G.D., M. Robbie-Ryan, V.H. Secor, et al. 2005. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 35 : 3478 3486.
60. Zappulla, J.P., M. Arock, L.T. Mars, et al. 2002. Mast cells: new targets for multiple sclerosis therapy? J. Neuroimmunol. 131 : 5 20.
61. Goldn, R. & H.P. Hartung. 2007. Towards individualized multiple sclerosis therapy. Lancet Neurol. 4 : 693 694.
62. Duthie, S.J., W. Johnson & V.L. Dobson. 1997. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mut. Res. 390 : 141 151.
63. Herrmann, K. 1976. Flavonols and flavones in food plants. J. Food Technol. 11 : 433 448.
64. Middleton, E. Jr., C. Kandaswami & T.C. Theoharides. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52 : 673 751.
65. Halliwell, B. 2001. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18 : 685 716.
66. Lu, F., M. Selak, J. O'Connor, et al. 2000. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177 : 95 103.
67. Ruuls, S.R., J. Bauer, K. Sontrop, et al. 1995. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56 : 207 217.
68. Kempuraj, D., B. Madhappan, S. Christodoulou, et al. 2005. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol. 145 : 934 944.
69. Kandere-Grzybowska, K., D. Kempuraj, J. Cao, et al. 2006. Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Bri. J. Pharmacol. 148 : 208 215.
70. Foreman, J.C. 1984. Mast cells and the actions of flavonoids. J. Allergy Clin. Immunol. 73 : 769 774.
71. Middleton, E. Jr. 1998. Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 439 : 175 182.
72. Kimata, M., N. Inagaki & H. Nagai. 2000. Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta Medica 66 : 25 29.
73. Kimata, M., M. Schchijo, T. Miura, et al. 1999. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy 30 : 501 508.
74. Aktas, O., T. Prozorovski, A. Smorodchenko, et al. 2004. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 173 : 5794 5800.
75. Hendriks, J.J., J. Alblas, S.M. Van Der Pol, et al. 2004. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J. Exp. Med. 200 : 1667 1672.
76. Hendriks, J.J., H.E. de Vries, S.M. Van Der Pol, et al. 2003. Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem. Pharmacol. 65 : 877 885.
77. Verbeek, R., A.C. Plomp, E.A. van Tol, et al. 2004. The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem. Pharmacol. 68 : 621 629.